- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about LMNL
Recent news which mentions LMNL
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 12, 2023
From Benzinga
Why SeaChange International Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
April 06, 2023
From Benzinga
Dow Rises 80 Points; MarketAxess Holdings Shares Slide
April 05, 2023
From Benzinga
Why Kura Sushi Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 05, 2023
From Benzinga
From Benzinga
Why Is Freight Technologies (FRGT) Stock Up 25% Today?
April 05, 2023
From InvestorPlace
Why Is Liminal Biosciences (LMNL) Stock Up 77% Today?
April 05, 2023
From InvestorPlace
Markets Mixed; US Trade Deficit Widens In February
April 05, 2023
From Benzinga
Earnings Scheduled For March 15, 2023
March 15, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
January 03, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
December 29, 2022
From Benzinga
Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday
August 09, 2022
From Benzinga
From Benzinga
From Benzinga
Americans’ Appetite for Vaccine Options Bodes Well for Ocugen
February 21, 2022
From InvestorPlace
From Benzinga
Liminal BioSciences Pauses Development Of Fezagepras, Outlines R&D Priorities For 2022
January 20, 2022
Tickers
LMNL
From Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
From Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
October 05, 2021
From Benzinga
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
August 20, 2021
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Monday
August 16, 2021
From Benzinga
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.